| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3884077 | Kidney International | 2009 | 4 Pages |
Abstract
The discovery of the calcium-sensing receptor (CaSR) and the development of calcimimetics have provided new insights into calcium homeostasis and new therapeutic opportunities for parathyroid-related disorders. However, the CaSR is also implicated in various other cellular processes, and the translational applications of calcimimetics may not be exclusively calcium-centric. Koleganova et al. describe a novel role for calcimimetics as vasculotropes, which provides the impetus for further studies to characterize their effects on vascular biology.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ziyad Al-Aly,